Fortrea Holdings (FTRE) EBT (2022 - 2026)
Fortrea Holdings (FTRE) posted EBT of -$12.3 million for Q1 2026, up 65.45% on a QoQ basis from -$35.6 million in Q4 2025, and up 97.76% year-over-year from -$6.2 million in Q1 2025.
Fortrea Holdings (FTRE) EBT (2022 - 2026) Analysis & Trends
Fortrea Holdings' EBT history runs 5 years deep, the most recent figure standing at -$12.3 million for Q1 2026.
- Quarterly EBT rose 97.76% year-over-year to -$12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$447.3 million (up 40.14% YoY) and the FY2025 annual result came in at -$983.0 million, down 257.45% from the prior year.
- EBT was -$12.3 million for Q1 2026 at Fortrea Holdings, up from -$35.6 million in the prior quarter.
- Across five years, EBT topped out at $83.6 million in Q2 2022 and bottomed at -$548.0 million in Q1 2025.
- A 5-year average of -$72.0 million and a median of -$32.2 million in 2025 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT sank 896.84% — and 2026, when it soared 97.76%.
- Fortrea Holdings' EBT stood at -$8.3 million in 2022, then tumbled by 559.04% to -$54.7 million in 2023, then plunged by 36.93% to -$74.9 million in 2024, then soared by 52.47% to -$35.6 million in 2025, then jumped by 65.45% to -$12.3 million in 2026.
- Business Quant data shows FTRE's EBT at -$12.3 million in Q1 2026, -$35.6 million in Q4 2025, and -$28.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Fortrea Holdings | 1.83 Bn | 1.68 Bn | 123.60 Mn | -12.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.30 Mn |
| Dec 31, 2025 | -35.60 Mn |
| Sep 30, 2025 | -28.70 Mn |
| Jun 30, 2025 | -370.70 Mn |
| Mar 31, 2025 | -548.00 Mn |
| Dec 31, 2024 | -74.90 Mn |
| Sep 30, 2024 | -35.80 Mn |
| Jun 30, 2024 | -88.60 Mn |
| Mar 31, 2024 | -75.70 Mn |
| Dec 31, 2023 | -54.70 Mn |
| Sep 30, 2023 | -21.90 Mn |
| Jun 30, 2023 | 36.60 Mn |
| Mar 31, 2023 | 9.50 Mn |
| Dec 31, 2022 | -8.30 Mn |
| Sep 30, 2022 | 74.20 Mn |
| Jun 30, 2022 | 83.60 Mn |